Stanford Biodesign co-founder joins Sofinnova Partners

Dr. Josh Makower [Image from his LinkedIn page]Sofinnova Partners — a prominent life sciences venture capital firm based in Paris, London, and Milan — has added Stanford Biodesign co-founder and director Dr. Joshua Makower as an advisory venture partner.

It’s been 23 years since Makower co-founded Stanford Biodesign alongside Dr. Paul Yock. They were instrumental in devising “The Biodesign Process” — used to teach students and industry leaders at Stanford and worldwide.

Makower is also the founder and executive chair of medical device incubator ExploraMed, which has launched 11 companies since 1995. His work has led to significant developments in the field — including the creation of NeoTract, maker of a device and procedure to treat an enlarged prostate; Acclarent, creator of devices for minimally invasive sinus surgeries; and TransVascular, which pioneered transvascular procedures. Teleflex, Johnson & Johnson, and Medtronic acquired the com…

Read more
  • 0

Inari Medical plans to buy LimFlow Medical for up to $415M

The LimFlow System for Transcatheter Arterialization of Deep Veins diverts blood from a diseased tibial artery to a tibial vein to deliver oxygen to a patient’s ischemic foot. [Illustration courtesy of LimFlow]Inari Medical (NASDAQ: NARI) + today announced a definitive agreement to purchase LimFlow Medical for up to $415 million.

The deal comes just weeks after Paris-based LimFlow won FDA premarket approval (PMA) for its breakthrough system to treat chronic limb-threatening ischemia (CLTI).

San Jose, California–based Inari said it expects to complete the acquisition by the end of 2023. Inari will pay $250 million in cash at closing, plus up to $165 million based on certain commercial and reimbursement milestones.

Medical Design & Outsourcing: How LimFlow’s foot-saving system prevents amputations in patients with no other options

Inari CEO Drew Hykes said the LimFlow acquisition “is closely aligned …

Read more
  • 0